Intas Pharmaceuticals Limited Tacrolimus Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Tacrolimus Export Records India — #4 Exporter, 588 Shipments, $22.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Tacrolimus

India Pharmaceutical Trade Intelligence

$201.2M299 Suppliers127 CountriesHS 30049099

ExportsIndia → UNITED STATES54.1%India → SLOVENIA11.9%

ImportsIRELAND → India$38.9M GERMANY → India$3.6M

#1 Supplier: SANDOZ PRIVATE #1 Buyer: ASCEND LABORATORIES

Intas Pharmaceuticals Limited — Tacrolimus Exporter #4 | $22.5M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Tacrolimus Exporter Profile

Indian Pharmaceutical Exporter · #4 for Tacrolimus · $22.5M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #4 Indian exporter of Tacrolimus with $22.5M in export value and 588 verified shipments. Intas Pharmaceuticals Limited holds a 11.2% market share in Tacrolimus exports across 13 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Tacrolimus Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Tacrolimus export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Tacrolimus?

Country	Value	Shipments	Share
UNITED STATES	$8.0M	236	58.3%
NETHERLANDS	$2.2M	128	16.0%
SPAIN	$972.5K	159	7.1%
FRANCE	$723.4K	16	5.3%
UNITED KINGDOM

Who Are the Top Buyers of Tacrolimus from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$5.2M	142
EVERSANA LIFE SCIENCES SERVICES LLC	UNITED STATES	$2.3M	73
TO THE ORDER.,	FRANCE	$1.0M	36
TO THE ORDER	SPAIN	$919.3K	100
EVERSANA LIFE SCIENCES SERVICESLLC	UNITED STATES	$386.4K	18
ACCORD UK	UNITED KINGDOM	$375.9K	15
PIERRE FABRE SANTE	FRANCE	$323.4K	8
BROCACEF NL : HUB	NETHERLANDS	$309.7K	15
INDUSTRIAL FARMACEUTICA	SPAIN	$276.8K	15
BROCACEF NL DUTCH	NETHERLANDS	$249.5K	8

Intas Pharmaceuticals Limited supplies Tacrolimus to 36 buyers globally. The largest buyer is EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES), followed by EVERSANA LIFE SCIENCES SERVICES LLC (UNITED STATES) and TO THE ORDER., (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Tacrolimus Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI TACROLIMUS CAP 1 MG	$1.3M	30
PHA.DRU & MEDI, TACROLIMUS CAP 1 MG USP	$697.8K	16
PHARMA DRUGS & MEDI TACROLIMUS OINTMEN,0	$486.8K	18
PHARMA DRUGS & MEDI TACROLIMUS CAP 5 MG	$483.7K	12
PHARMA DRUGS & MEDI TACROLIMUS CAP 0.5 M	$330.4K	10
PHA.DRU & MEDI, Takrozem, Tacrolimus oin	$323.4K	8
PHR DRUGS&MEDI TACROLIMUS CAP USP 1 MG 1	$297.5K	6
PHA.DRU & MEDI, TACROLIMUS CAP 1 MG USP100C (US-ACCO EACH HARD GELATIN CAPSULECONTAINS:TACROLIMUS MONOHYDRATE EQUIVALENOS	$294.4K	6
PHARMA DRUGS & MEDI TACROLIMUS CAP 1 MG USP 100C US-ACCO AS PER DOCUMENT	$275.0K	7
PHA.DRU & MEDI, TACROLIMUS OINT 0.1% - 3	$249.3K	8

Intas Pharmaceuticals Limited exports 244 distinct Tacrolimus formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI TACROLIMUS CAP 1 MG with 30 shipments worth $1.3M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Tacrolimus Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	SANDOZ PRIVATE LIMITED	$36.9M	737	14	$50.0K
4	INTAS PHARMACEUTICALS LIMITED ★	$22.5M	588	13	$38.2K
2	ALKEM LABORATORIES LIMITED	$8.4M	168	3	$50.0K
5	PANACEA BIOTEC PHARMA LIMITED	$5.2M	103	19	$50.0K

Intas Pharmaceuticals Limited ranks #4 among 299 Indian Tacrolimus exporters. Average shipment value of $38.2K compared to the market average of $309.1K. The closest competitors by value are SANDOZ PRIVATE LIMITED and ALKEM LABORATORIES LIMITED.

Which Indian Ports Ship Tacrolimus Exports?

Port	Shipments	% Share
SAHAR AIR	741	16.1%
SAHAR AIR CARGO ACC (INBOM4)	645	14.0%
DELHI AIR CARGO ACC (INDEL4)	398	8.6%
NHAVA SHEVA SEA (INNSA1)	358	7.8%
DELHI AIR	320	6.9%
AHEMDABAD AIR ACC (INAMD4)	175	3.8%
JNPT/ NHAVA SHEVA SEA	169	3.7%
Bombay Air	141	3.1%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Tacrolimus Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Tacrolimus shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 608 individual customs records matching Intas Pharmaceuticals Limited exporting Tacrolimus, covering 244 formulations to 13 countries via 36 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 127+ countries, 727+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Tacrolimus

Tacrolimus

Intas Pharmaceuticals Limited — Tacrolimus Exporter Profile

Intas Pharmaceuticals Limited — Tacrolimus Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Tacrolimus?

Who Are the Top Buyers of Tacrolimus from Intas Pharmaceuticals Limited?

What Is India's Total Tacrolimus Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Tacrolimus Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Tacrolimus Exporters?

What Tacrolimus Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Tacrolimus to Key Markets

United States — FDA

How Does Intas Pharmaceuticals Limited Compare to Nearest Tacrolimus Exporters?

Which Indian Ports Ship Tacrolimus Exports?

What Other Immunosuppressants Products Does Intas Pharmaceuticals Limited Export?

Tacrolimus — Export Intelligence Video

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Tacrolimus Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Tacrolimus Export Data from Intas Pharmaceuticals Limited

Tacrolimus Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source